Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hana Financial Group is a leading South Korean financial holding company that plays a significant role in the life sciences and healthcare sectors through its specialized subsidiaries. The group's venture capital arm, Hana Ventures, is a prominent investor in early-stage biotech and healthcare startups, while its investment banking unit, Hana Securities, is a top underwriter for biotechnology IPOs on the KOSDAQ. Additionally, the group manages real estate investments in life science properties and provides specialized financing solutions for healthcare providers. While not a drug developer itself, Hana Financial Group is a critical infrastructure and capital provider for the global and domestic Korean biotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hana Financial.